DPH3B expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.569200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.027400E-01
Normal-vs-Stage2
4.185400E-01
Normal-vs-Stage3
6.974200E-01
Normal-vs-Stage4
3.221400E-01
Stage1-vs-Stage2
6.873400E-01
Stage1-vs-Stage3
1.560370E-01
Stage1-vs-Stage4
4.001800E-01
Stage2-vs-Stage3
1.857210E-01
Stage2-vs-Stage4
2.369200E-01
Stage3-vs-Stage4
1.608830E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.491600E-01
Normal-vs-AfricanAmerican
3.878000E-01
Normal-vs-Asian
9.838600E-01
Caucasian-vs-AfricanAmerican
4.362600E-01
Caucasian-vs-Asian
1.482230E-01
AfricanAmerican-vs-Asian
1.405800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.115000E-01
Normal-vs-Female
3.997600E-01
Male-vs-Female
4.475000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.763800E-01
Normal-vs-Age(41-60Yrs)
2.445600E-01
Normal-vs-Age(61-80Yrs)
5.862000E-01
Normal-vs-Age(81-100Yrs)
5.888800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.999600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.870200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.828000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.011900E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.803230E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.063800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.134200E-01
Normal-vs-Daily Drinker
7.851400E-01
Normal-vs-Weekly Drinker
4.236200E-01
Normal-vs-Occasional Drinker
3.788600E-01
Normal-vs-Social Drinker
1.081630E-01
Non Drinker-vs-Daily Drinker
9.602800E-01
Non Drinker-vs-Weekly Drinker
2.168800E-01
Non Drinker-vs-Occasional Drinker
2.106800E-01
Non Drinker-vs-Social Drinker
6.177000E-03
Daily Drinker-vs-Weekly Drinker
3.698200E-01
Daily Drinker-vs-Occasional Drinker
3.679600E-01
Daily Drinker-vs-Social Drinker
4.334300E-02
Weekly Drinker-vs-Occasional Drinker
8.952000E-01
Weekly Drinker-vs-Social Drinker
2.892400E-01
Occasional Drinker-vs-Social Drinker
1.678990E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.703000E-01
Normal-vs-Grade 2
9.925800E-01
Normal-vs-Grade 3
9.483600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.375500E-02
Grade 1-vs-Grade 3
9.920400E-03
Grade 1-vs-Grade 4
8.703000E-01
Grade 2-vs-Grade 3
2.613800E-01
Grade 2-vs-Grade 4
9.925800E-01
Grade 3-vs-Grade 4
9.483600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.339800E-01
Normal-vs-NonDiabetic
4.565800E-01
Diabetic-vs-NonDiabetic
1.620560E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.524400E-01
Normal-vs-NoPancreatitis
5.060800E-01
Pancreatitis-vs-NoPancreatitis
9.769000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.393000E-01
Normal-vs-N1
4.150000E-01
N0-vs-N1
8.555600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.424000E-01
Normal-vs-TP53-NonMutant
6.087400E-01
TP53-Mutant-vs-TP53-NonMutant
1.791410E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
